Page last updated: 2024-09-05
avasimibe and rg108
avasimibe has been researched along with rg108 in 1 studies
Compound Research Comparison
| Studies (avasimibe) | Trials (avasimibe) | Recent Studies (post-2010) (avasimibe) | Studies (rg108) | Trials (rg108) | Recent Studies (post-2010) (rg108) |
|---|---|---|---|---|---|
| 77 | 6 | 30 | 84 | 0 | 78 |
Protein Interaction Comparison
| Protein | Taxonomy | avasimibe (IC50) | rg108 (IC50) |
|---|---|---|---|
| DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | 0.115 | |
| DNA (cytosine-5)-methyltransferase 3B | Homo sapiens (human) | 0.9 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Ahn, HM; Du, Y; Fan, D; Fu, H; Ivanov, AA; Liang, B; Qian, K; Troha, AH; Yang, X | 1 |
Other Studies
1 other study(ies) available for avasimibe and rg108
| Article | Year |
|---|---|
Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer.
Topics: Antineoplastic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Discovery; Humans; MAP Kinase Kinase 3; Molecular Docking Simulation; Molecular Structure; Neoplasms; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myc; Small Molecule Libraries; Structure-Activity Relationship | 2021 |